KPF
EUCRW

K2 Principal Fund’s Eucrates Biomedical Acquisition Corp. Warrant EUCRW Stock Holding History

K2 Principal Fund’s Portfolio EUCRW Stock Details EUCRW Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-34,509
Closed -$1.14K – 300
2023
Q1 		$1.14K Buy
+34,509
New +$1.14K ﹤0.01% 186